Edward C. Franklin

From Wikipedia, the free encyclopedia

Edward C Franklin (April 14, 1928–February 20, 1982) was an American pioneering immunologist and physician. [1] [2] The Franklin's disease has been designated in his name as a result of his discovery of the heavy chain disease of which the Franklin disease is a variety of.[1][2] An award has been established in his name - Edward C. Franklin Award which is given for achievements in immunology.[3] Franklin was a professor of medicine at the New York University School of Medicine,[1] a member of the National Academy of Sciences,[2] president of the American Society for Clinical Investigation,[1] director of Irvington House Institute.[2] Franklin made major gains in the studies of the aging process with a discovery of a protein known as amyloid.[1][2] Franklin played key role in the fight against arthritis.[1][2][4] The New York Times called Franklin "an international authority on the human immune system".[1]

Life and career

Franklin was born in Berlin, Germany in 1928 and immigrated to the USA in 1939 as an escapee from Nazism. He received his undegraduate degree from Harvard University in 1946 and his medical degree from the N.Y.U. School of Medicine in 1950.[1]

External links

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 New York Times:DR. EDWARD C. FRANKLIN DIES; HUMAN-IMMUNOLOGY PIONEER,by WALTER H. WAGGONER, February 25, 1982
  2. ↑ 2.0 2.1 2.2 2.3 2.4 2.5 National Academies Press, Biographical Memoirs, V.78, EDWARD C. FRANKLIN, BY HENRY METZGER
  3. ↑ The 1983 Edward C. Franklin Award for distinguished achievements in basic and clinical immunology,Angelo O. Carbonara
  4. ↑ New York Times:GAIN IS REPORTED IN ARTHRITIS FIGHT; Experiments Have Isolated Rheumatoid Factor;By BESS FURMAN,December 07, 1957,
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.